Related Experiment Video
Updated: Mar 4, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
26.6K
Diabetes medication persistence, different medications have different persistence rates.
Michal Shani1, Alex Lustman1, Shlomo Vinker2
1Department of Family Medicine Central District, Clalit Health Service, Mazkeret Batya, Israel; Department of Family Medicine Sackler Faculty of Medicine, Tel Aviv University, Israel.
Primary Care Diabetes
|April 20, 2017
Summary
Diabetic patients show varying persistence with oral medications like metformin and statins. Good adherence to one drug often predicts better persistence with others, highlighting the importance of medication management.
Area of Science:
- Endocrinology and Metabolism
- Pharmacology
- Public Health
Background:
- Type 2 diabetes mellitus (T2DM) management relies heavily on oral medications.
- Patient adherence to long-term medication regimens is a significant challenge in chronic disease management.
- Understanding medication persistence is crucial for optimizing therapeutic outcomes in diabetic populations.
Purpose of the Study:
- To assess the persistence rates of type 2 diabetic patients with various oral medications.
- To investigate the relationship between persistence to different classes of diabetes-related medications.
- To identify factors associated with good medication persistence in a large cohort of diabetic patients.
Main Methods:
- Retrospective cohort study of T2DM patients over 40 years old in Israel.
- Inclusion criteria: diagnosed before 2008, filled prescriptions annually 2008-2010.
- Good persistence defined as ≥9 monthly prescriptions in 2009 for metformin, glibenclamide, acarbose, statins, ACE inhibitors (ACEI), and angiotensin II receptor antagonists (ARBs).
Main Results:
- A total of 21,357 patients were analyzed, with an average age of 67.0 years.
- Good medication persistence rates varied: ARBs (78.8%), ACEI (69.0%), statins (66.6%), acarbose (67.8%), metformin (58.6%), and glibenclamide (55.3%).
- Higher persistence was observed for patients taking multiple medications, and good persistence with one medication class was linked to better persistence with others.
Conclusions:
- Oral antidiabetic and cardiovascular medications exhibit distinct persistence patterns in T2DM patients.
- Good medication persistence for any single agent serves as a reliable indicator of overall adherence.
- Interventions to improve medication persistence in diabetes care may enhance adherence to multiple therapies and improve glycemic control.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
01:26Oral Drug Delivery Systems: Continuous-Release Systems
88
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
88
01:16Insulin: Dosing Regimen and Adverse Effects
959
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
959
01:22Diabetes Mellitus: Overview and Type I Subtype
5.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
746
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
746
01:22Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K